Galvus 50 mg
Galvus 50 mg is a member of a class of anti-diabetic medications known as ‘dipeptidyl peptidase 4 (DPP-4)’ inhibitors that is used to treat type 2 diabetes, particularly in people whose blood sugar levels cannot be maintained alone via diet and exercise. Galvus 50 mg is a prescription medication that may be used alone or in combination with other medications. Type 2 diabetes is a chronic (long-lasting) disease that impairs our body’s glucose metabolism. Individuals with type 2 diabetes either create insufficient insulin or insulin is unable to accomplish its role in the body (insulin resistance). Individuals in their middle to late twenties or older are more likely to develop type 2 diabetes, often known as adult-onset diabetes.
Galvus 50 mg includes Vildagliptin, a chemical messenger termed ‘incretin’ hormone that works by blocking its breakdown. This hormone is secreted following a meal to stimulate the pancreas to generate insulin. Galvus 50 mg boosts the level of the ‘incretin’ hormone, allowing the pancreas to produce enough insulin to decrease elevated blood sugar levels. Thus, Galvus 50 mg aids in the management of type 2 diabetes mellitus.
Galvus 50 mg should be taken with or without food as directed by your doctor and should be swallowed whole with a glass of water. Avoid crushing, chewing, or breaking it. Your doctor will choose the frequency with which you should take Galvus 50 mg based on your medical condition. In some situations, you may feel dizziness, nausea, headache, excessive perspiration, hypoglycemia, and trembling. The majority of these Galvus 50 mg side effects are mild and resolve on their own. However, if any of the above-mentioned adverse effects persist or worsen, please visit your physician.
Please inform your doctor if you are allergic to Galvus 50 mg or any other medications. Galvus 50 mg is contraindicated in children under the age of 18. Please contact your doctor if you are pregnant or nursing, or if you are on dialysis, before using Galvus 50 mg. Avoid drinking alcohol while using Galvus 50 mg, as it may cause an increase or drop in blood sugar levels. Galvus 50 mg is contraindicated in persons suffering from diabetic ketoacidosis or type 1 diabetes. Inform your doctor if you have type 1 diabetes, diabetic ketoacidosis (excessive blood acids called ketones), pancreas, kidney, liver, or heart illness before using Galvus 50 mg.
Galvus 50 mg indications Type 2 diabetic mellitus
Galvus 50 mg contains Vildagliptin, an anti-diabetic medication used to treat type 2 diabetes, particularly in those for whom diet and exercise alone are unable to regulate blood sugar levels. Galvus 50 mg inhibits the breakdown of incretin hormones that regulate blood sugar levels, including glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic peptide (GIP). As a result, the levels of these two hormones that are released following a meal are increased. Galvus 50 mg stimulates pancreatic insulin production and inhibits hepatic glucagon synthesis. As a result, it aids in the regulation of blood sugar levels and the prevention of future complications associated with diabetes. Along with Galvus 50 mg, a healthy diet and regular exercise will yield the best benefits.
Galvus 50 mg should be taken exactly as suggested by your doctor. Galvus 50 mg daily, with or without food, and consume whole with a glass of water. Avoid crushing or breaking it. Adhere to the diet suggested by a physician.
Storage Keep out of direct sunlight and in a cool, dry area.
Galvus 50 mg Adverse Reactions
Galvus 50 mg, like many medications, may produce several common adverse effects such as dizziness, nausea, headache, excessive perspiration, low blood sugar levels, and shaking. The majority of Galvus 50 mg side effects are mild and resolve on their own. However, if adverse effects continue, you should visit your physician.
Adverse Drug Reactions
Kindly inform your doctor if you are allergic to Vidagliptin or any other medication. Vidagliptin is not suggested for children younger than the age of 18 years. Please contact your doctor if you are pregnant or breastfeeding, or if you are on dialysis, before using Vidagliptin. Avoid drinking alcohol while taking Vidagliptin, as it may cause an increase or drop in blood sugar levels. Vidagliptin is contraindicated in persons suffering from diabetic ketoacidosis or type 1 diabetes. When taking Vidagliptin, have small, regular meals and prevent prolonged fasting. Be on the lookout for hypoglycemia (low blood sugar) symptoms such as perspiration, disorientation, palpitations, shivering, excessive thirst, dry mouth, dry skin, and frequent urination. If you suffer any of these symptoms, swallow 5-6 candies, 3 glucose biscuits, or 3 teaspoons of honey/sugar immediately and visit your doctor. Carry these with you at all times, especially on lengthy journeys. Inform your doctor if you have type 1 diabetes, diabetic ketoacidosis (high amounts of blood acids called ketones), pancreas, kidney, liver, or heart illness.
Interactions Between Drugs
Interactions Between Drugs: Vidagliptin may interact with antipsychotic medications (aripiprazole, clozapine), corticosteroids (dexamethasone, prednisolone), glaucoma medications (acetazolamide), cardiac stimulants (dopamine), and thyroid medications (levothyroxine) (bendroflumethiazide).
Vidagliptin may interact with alcohol. As a result, avoid alcohol consumption while taking Vidagliptin, as it may result in abnormally high or low blood sugar levels.
Inform your doctor if you have type 1 diabetes, diabetic ketoacidosis (excessive blood acids called ketones), pancreas, kidney, liver, or heart disease before using Vidagliptin.
It is recommended that you avoid alcohol while taking Vidagliptin since it may produce abnormally high or low blood sugar levels.
Vidagliptin is a pregnancy Category B medication that is not normally suggested for pregnant women. However, if you are pregnant, you should see a physician before using Vidagliptin.
Vidagliptin is not excreted in breast milk and is therefore not suggested for breastfeeding mothers. If you are a breastfeeding mother, please check your doctor before using Vidagliptin.
Vidagliptin may induce dizziness in certain individuals. As a result, refrain from driving if you have dizziness after taking Vidagliptin.
Vidagliptin should be used with caution, particularly if you have a family history of liver disease/conditions. Your doctor may alter the dose as necessary.
Vidagliptin should be used with caution, particularly if you have a family history of kidney disease/conditions. Your doctor may alter the dose as necessary.
Advice on Diet and Lifestyle
Exercise regularly for at least 30 minutes per day, such as cycling, walking, jogging, dancing, or swimming. Spend at least 150 minutes per week exercising.
Maintain a healthy body weight, as obesity is also associated with diabetes onset.
Consume a low-fat, low-sugar diet. Substitute whole grains, fruits, and vegetables for carbs-containing foods, as carbohydrates convert to sugars, resulting in high blood sugar.
Avoid alcohol and tobacco usage.
Liver function tests are advised prior to initiating Vidagliptin medication, every three months for the first year, and at regular intervals thereafter to monitor for evidence of elevated liver enzymes.
Additionally, this item is non-returnable.
Concern for Patients
Type 2 diabetes is a chronic (long-lasting) disease in which the body is unable to adequately utilize insulin. As a result, persons with type 2 diabetes either do not make enough insulin or are insulin resistant. Middle-aged or older adults are more prone to develop type 2 diabetes, sometimes called adult-onset diabetes. Increased thirst, frequent urine at night, poor wound healing, increased hunger, weariness, and blurred eyesight are all symptoms of type 2 diabetes. In certain circumstances, weight increase may occur, whereas in rare instances, weight reduction may occur. Type 2 diabetes also has complications such as nerve damage, renal difficulties, damaged retina of the eyes or blindness, amputation of limbs, sexual dysfunction, and an increased risk of heart attack or stroke.
Galvus 50 mg contains Vildagliptin, an anti-diabetic medication that works by inhibiting the breakdown of incretin hormones, including glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic peptide (GIP), which are responsible for blood sugar regulation. As a result, the levels of these two hormones are increased. Vidagliptin stimulates pancreatic insulin production and inhibits hepatic glucagon synthesis. As a result, it aids in the regulation of blood sugar levels.
Vidagliptin may be used with metformin. However, before using Vidagliptin with other medications, see your doctor to ensure that the dose is adjusted appropriately.
Vidagliptin should be taken with great caution in patients who currently have or have had pancreatitis (pancreas edema), since it may raise the risk of recurrent pancreatitis or exacerbate the illness. However, if you have symptoms such as nausea, vomiting, or stomach discomfort, visit a physician immediately.
Vidagliptin does not produce hypoglycemia on its own. However, low blood sugar levels may occur when Vidagliptin is combined with other antidiabetic medications, when alcohol is consumed, when exercise is increased above normal, or when snacks or meals are delayed or missed. However, if you suffer symptoms of low blood pressure such as dizziness, nausea, lightheadedness, dehydration, or fainting, you should visit a physician.
No, it is not suggested that you stop taking Vidagliptin on your own because abruptly stopping Vidagliptin may result in recurrent symptoms or worsen the illness. If you have any problems while taking Vidagliptin, please tell your doctor so that an alternative medication can be administered.
Diabetes-related skin lesions are a typical consequence of the disease. However, it is important that you follow your doctor’s foot and skincare instructions, and that you visit a doctor if you develop any new ulcers or blisters while taking Vidagliptin.